Who's buying InMed Pharmaceuticals Inc.?

INM insider buying, 13F and 13D filings

• Oct 15, 2026Form 4 · 10% owner
  ADAR1 Capital Management, LLC (+1 joint): Bought $13K on the open market
  9.6K shares at ~$1.33, traded 2026-10-13 to 2026-10-15. Now holds 955.5K shares (stake up 1%).
  View the filing on SEC EDGAR ↗

Signals come from SEC filings: Form 4 (insiders, filed within 2 business days), 13F (fund holdings, up to 45 days after quarter end) and Schedule 13D (5%+ activist stakes). This page reports what the filings show; it is not investment advice.